263 related articles for article (PubMed ID: 15766030)
21. Watanidipine. AE 0047, Calbren, GJ 0956, Vatanidipine.
Drugs R D; 2002; 3(5):331-6. PubMed ID: 12455154
[No Abstract] [Full Text] [Related]
22. Lacidipine. Aponil, Caldine, GR 43659, GR 43659X, GX 1048, Lacimen, Lacipil, Lacirex, Midotens, Motens, SN 305, Viapres.
Drugs R D; 2002; 3(5):324-30. PubMed ID: 12455153
[No Abstract] [Full Text] [Related]
23. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
[TBL] [Abstract][Full Text] [Related]
24. [Calcium antagonists lower not only blood pressure. Arteriosclerosis is braked too].
MMW Fortschr Med; 2001 Nov; 143(46):60. PubMed ID: 11759606
[No Abstract] [Full Text] [Related]
25. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
26. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study.
Martinez-Martin FJ; Saiz-Satjes M
Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1347-55. PubMed ID: 19018688
[TBL] [Abstract][Full Text] [Related]
27. Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine.
Pruijm MT; Maillard MP; Burnier M
Vasc Health Risk Manag; 2008; 4(6):1159-66. PubMed ID: 19337529
[TBL] [Abstract][Full Text] [Related]
28. Calcium antagonists should continue to be used for first-line treatment of hypertension.
Epstein M
Arch Intern Med; 1995 Nov; 155(20):2150-6. PubMed ID: 7487236
[No Abstract] [Full Text] [Related]
29. How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension.
Tocci G; Desideri G; Roca E; Calcullo C; Crippa M; De Luca N; Gaudio GV; Lonati LM; Orselli L; Scuteri A; Vulpis V; Acone B; Zaninelli A;
High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):25-34. PubMed ID: 29197935
[TBL] [Abstract][Full Text] [Related]
30. Should dihydropyridines be used as first-line drugs in the treatment of hypertension? The con side.
Furberg CD; Psaty BM
Arch Intern Med; 1995 Nov; 155(20):2157-61. PubMed ID: 7487237
[No Abstract] [Full Text] [Related]
31. [New calcium antagonist. Therapy of hypertension becomes more tolerable].
MMW Fortschr Med; 2001 Oct; 143(40):56-7. PubMed ID: 11692852
[No Abstract] [Full Text] [Related]
32. Lercanidipine in the treatment of hypertension.
Beckey C; Lundy A; Lutfi N
Ann Pharmacother; 2007 Mar; 41(3):465-73. PubMed ID: 17341540
[TBL] [Abstract][Full Text] [Related]
33. [Calcium antagonists in treatment of hypertension].
Landmark K; Reikvam A
Tidsskr Nor Laegeforen; 2009 Dec; 129(23):2488-9. PubMed ID: 19997138
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of an L- and N-type calcium channel blocker in hypertensive patients with neurovascular compression of the rostral ventrolateral medulla.
Aota Y; Morimoto S; Sakuma T; Morita T; Jo F; Takahashi N; Maehara M; Ikeda K; Sawada S; Iwasaka T
Hypertens Res; 2009 Aug; 32(8):700-5. PubMed ID: 19521420
[TBL] [Abstract][Full Text] [Related]
35. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
Morimoto S; Yano Y; Maki K; Iwasaka T
J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
[TBL] [Abstract][Full Text] [Related]
36. Calcium-channel blockers in the management of essential hypertension.
Wallis DE
Compr Ther; 1989 Nov; 15(11):14-9. PubMed ID: 2684479
[TBL] [Abstract][Full Text] [Related]
37. Clinical case: Peritoneal dialysis patient with cloudy peritoneal fluid following administration of calcium antagonists.
Viñolo López MC; Gutiérrez Rivas PC; Liébana Cañada A; Gil Cunquero JM; Merino García E
Nefrologia; 2011; 31(5):624. PubMed ID: 21959742
[No Abstract] [Full Text] [Related]
38. [Modern calcium channel blockade. Lowering blood pressure with added benefits].
MMW Fortschr Med; 2001 Feb; 143(6):57. PubMed ID: 11247372
[No Abstract] [Full Text] [Related]
39. Calcium antagonists "some agents lower blood pressure and still put the heart at risk"?
Leenen FH
Clin Exp Hypertens; 1999; 21(5-6):823-34. PubMed ID: 10423105
[TBL] [Abstract][Full Text] [Related]
40. Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study.
Martínez Martín FJ
Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):863-9. PubMed ID: 19589122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
